Latest / Unbreakable Vitality / Why Retatrutide May Force Medicine to Rethink Chronic Disease Entirely
Transcript
- 0:00SPEAKER_01: Ever feel like you're doing all the right things and still wondering why your body feels off?
- 0:06SPEAKER_01: You eat well, you train hard, your labs say you're fine, but deep down you know something's slipping.
- 0:12SPEAKER_01: You're not alone, and you're not crazy.
- 0:15SPEAKER_01: I'm Daniel Rasmussen, founder of Echelon Center for Longevity, and I've spent two decades helping high performers like you to reverse aging, reignite vitality, and finally get answers.
- 0:24SPEAKER_01: On Unbreakable Vitality, we go upstream.
- 0:27SPEAKER_01: We talk peptides, stem cells, precision diagnostic testing, reversing the age of your arteries, all the innovative science-based tools to take back your health span so that your next decades are your best yet.
- 0:38SPEAKER_01: Because aging is real, but decline is optional.
- 0:42SPEAKER_01: Welcome back to Unbreakable Vitality.
- 0:45SPEAKER_01: Today we're talking about one of the most misunderstood compounds in modern metabolic medicine, retitrutide.
- 0:52SPEAKER_01: Because most people think that this is just another weight loss peptide.
- 0:56SPEAKER_01: Well, it's not.
- 0:58SPEAKER_01: What makes retitrutide so interesting is not simply the amount of weight loss that weight that people lose, it's what appears to happen underneath the surface.
- 1:08SPEAKER_01: Visceral fat reduction, improved insulin sensitivity, changes in liver health.
- 1:13SPEAKER_01: I see cardiovascular biomarkers improving.
- 1:16SPEAKER_01: I see leptin signaling improving.
- 1:19SPEAKER_01: We see metabolic flexibility being restored in people who've lost it over decades.
- 1:23SPEAKER_01: This peptide may represent something much, much bigger.
- 1:26SPEAKER_01: A shift in how we think about chronic disease itself.
- 1:30SPEAKER_01: Begin with pain.
- 1:31SPEAKER_01: A lot of people feel trapped inside a metabolism that's no longer responding.
- 1:35SPEAKER_01: They eat less, they exercise harder, they try all these supplements, they try dieting, and still, visceral fat accumulates, fatty liver progresses, energy declines, blood sugar worsens, inflammation increases, recovery slows down, and eventually they're told, yeah, you're just getting older, get used to it.
- 1:55SPEAKER_01: Aging isn't for sissies, right?
- 1:57SPEAKER_01: Well, what if uh much of what we call aging is actually metabolic dysfunction accumulating over time?
- 2:04SPEAKER_01: Insight and research is where retitrutide becomes fascinating.
- 2:08SPEAKER_01: Unlike semaglutide, which primarily targets GLP1 receptors, or trzeptide, which combines GLP1 and GIP activity, retitrutide ads a third pathway.
- 2:19SPEAKER_01: This is called glucagon receptor agonism.
- 2:23SPEAKER_01: And that matters because glucagon signaling appears to significantly increase energy expenditure and fat mobilization.
- 2:31SPEAKER_01: Uh phase two obesity studies followed participants for approximately 48 weeks, and the studies showed and demonstrated the average weight reduction approaching 24% in higher dose groups.
- 2:47SPEAKER_01: But the more interesting, for me anyway, the more interesting results came from the findings that were metabolic.
- 2:56SPEAKER_01: Research showed improvements in fasting glucose, insulin sensitivity, the triglycerides improved, blood pressure improved, liver fat markers, waist circumference, inflammatory cardiovascular risk markers, and importantly, retitruitide appears especially effective at reducing visceral adibose tissue or fat tissue, visceral fat.
- 3:18SPEAKER_01: And that matters because visceral fat is metabolically active inflammatory tissue strongly associated with inflammation, insulin resistance, fatty liver disease, cardiovascular disease, cognitive decline, which you guys is called type 3 diabetes.
- 3:35SPEAKER_01: This should scare the heck out of you, and accelerated aging.
- 3:39SPEAKER_01: So when we narrow the real problem down, it's not simply excess body weight.
- 3:44SPEAKER_01: The body weight is a symptom of all these disease processes going on.
- 3:48SPEAKER_01: It's metabolic signaling dysfunction.
- 3:50SPEAKER_01: And this is where many current weight loss approaches fall short.
- 3:54SPEAKER_01: Now, semaglutide and trzeptide, can they help with weight reduction?
- 3:58SPEAKER_01: Sure.
- 3:59SPEAKER_01: But clinically, what we see goes along with the fat is massive amounts of muscle tissue loss.
- 4:07SPEAKER_01: Uh, where, you know, in older individuals where they're already facing the decline of sarcopenia, this is not good.
- 4:15SPEAKER_01: When you lose muscle mass and bone density loss, uh you're in trouble.
- 4:20SPEAKER_01: You're you're headed down the wrong path there.
- 4:23SPEAKER_01: So uh another side effect of the GLP1s just by themselves is excessive appetite suppression, uh, reduced training capacity.
- 4:32SPEAKER_01: As you're losing muscle mass, you're moving more.
- 4:34SPEAKER_01: You guys, you're losing muscle mass, which is one of your main metabolic organs of your embodied your entire body.
- 4:41SPEAKER_01: If you're burning off your muscle mass and churning it with semaglutide and trzepatide, don't get me wrong, this can also have a red happen with regitrutide, but the risk is significantly less.
- 4:51SPEAKER_01: And we know how to mitigate this by working looking at your labs and working with people in a uh mentorship membership program.
- 4:59SPEAKER_01: And so the other aspect about GLP1's trzepatide and semaglutide is the fact that when people hit their target weight, not only do they look like a melted candle, you know, weakened, their cheeks are hollow, they look emaciated.
- 5:16SPEAKER_01: It's not a healthy look.
- 5:17SPEAKER_01: All these celebrities you see now are uh have the semaglutide face or the trzepatide face.
- 5:24SPEAKER_01: So after you stop these GLP1s, the the percentage of people that rebound weight gain after discontinuation is extremely high.
- 5:34SPEAKER_01: Uh and because if the underlying metabolism has been wrecked by these GLP1s, not enhanced, it's not rebuilt.
- 5:43SPEAKER_01: The system tends to drift back towards that dysfunction.
- 5:46SPEAKER_01: And this is why we think about reditrutide differently.
- 5:50SPEAKER_01: It's not as a crash weight loss tool, but we use it as a metabolic reprogramming opportunity.
- 5:57SPEAKER_01: So what becomes especially interesting is maintenance dosing, which I will probably never stop taking retruitide at this point, you know, 0.1 milligrams per week, uh, as long as I can for the rest of my life.
- 6:12SPEAKER_01: For the longevity, the anti-inflammatory, and just the metabolic signaling.
- 6:18SPEAKER_01: You know, this is not a drug, it is a signal that your cells listen to.
- 6:23SPEAKER_01: It is metabolic signaling, and it's restoring that.
- 6:26SPEAKER_01: And it's a therapy, it's a longevity tool to keep your metabolism humming along healthily for decades to come.
- 6:35SPEAKER_01: This is a wonder peptide stack.
- 6:39SPEAKER_01: These three peptides put together GLP1, a GIP, and a glucagon agonist.
- 6:46SPEAKER_01: This is a magic, this is a master class of uh biochemical and biopharmacological, pharmacological engineering.
- 6:56SPEAKER_01: And what becomes especially interesting is there's growing clinical interest in this very low-dose maintenance strategy uh with ratitrutide, sometimes around, like I said, that 0.1 milligram weekly.
- 7:10SPEAKER_01: So this is not, this is where it shifts from uh weight loss, but more shifting more towards long-term metabolic support.
- 7:18SPEAKER_01: Because the goal shifts from how much weight can we lose to how do we preserve metabolic flexibility, insulin sensitivity, uh, cardiovascular health, and body composition over decades, making your next decades their best.
- 7:33SPEAKER_01: You're going to be functioning metabolically in your 60s, 70s, and maybe even your 80s, uh, like a 20 or a 30-year-old does.
- 7:42SPEAKER_01: Uh this completely different conversation.
- 7:44SPEAKER_01: And from longevity perspective, that's the more important one in my eyes, rather than just quick, quick, quick fix weight loss of uh you know the trend of the GLP ones.
- 7:56SPEAKER_01: Don't get me wrong, don't get me wrong.
- 7:57SPEAKER_01: Weight loss is good because if you're overweight, you are you have systemic inflammation, you've got fatty liver disease, insulin resistance, cardiovascular risk, type 3 diabetes on the loom, you've got, you name it, you've got all of the chronic disease metabolic that are epidemic in the United States.
- 8:14SPEAKER_01: And these are all reversible, preventable causes of death.
- 8:18SPEAKER_01: The number one preventable cause of death is cardiovascular disease.
- 8:22SPEAKER_01: And that is not just in the US, that is worldwide.
- 8:25SPEAKER_01: And if you can reverse that by getting on retitrutide and uh finding out what your blood markers say, your deficiencies, your potential undetected infections, systemic inflammation, mitochondrial dysfunction, if you address those three, those big three, you have eliminated the cause of 99.9% of all the chronic illness out there.
- 8:48SPEAKER_01: So the smartest use of retitreetide is not as a standalone peptide.
- 8:53SPEAKER_01: It's part of a larger longevity system.
- 8:55SPEAKER_01: And that means preserving muscle through resistance training, supporting mitochondrial function, protecting your heart, which is the most important muscle in your body, improving your recovery after workouts and being uh active, strategically using nutrition, tactical nutrition, monitoring your biomarkers over time, uh, building a system that the body can sustain long term, because the goal is not temporary weight loss, the goal is metabolic resilience.
- 9:24SPEAKER_01: So if you've struggled with weight, insulin resistance, visceral fat, or metabolic dysfunction, that does not mean that your body is broken.
- 9:32SPEAKER_01: It may simply mean that your metabolism has just been trapped in the wrong signaling environment for much too long, far too long.
- 9:39SPEAKER_01: And once those signals begin changing, the body can respond in remarkable ways.
- 9:44SPEAKER_01: Retitrutide may end up being remembered for far more than weight loss.
- 9:49SPEAKER_01: It may become one of the first compounds that forces medicine to rethink chronic metabolic disease entirely, because this is not just about shrinking the body, it's about restoring metabolic intelligence.
- 10:02SPEAKER_01: So if you're curious whether a peptide like retitrutide could fit into a larger longevity strategy, not just for weight loss, but for metabolic health, body composition, long-term resilience, we offer a health span assessment.
- 10:14SPEAKER_01: It's a no-pressure conversation where we evaluate your current metabolic health, your biomarkers, your goals, and whether a structured peptide strategy makes sense for you.
- 10:23SPEAKER_01: No generic protocols, no one size fits all protocols, no guesswork.
- 10:28SPEAKER_01: It's just precision.
- 10:30SPEAKER_01: Go to uh agelessfuture seattle.com and uh hit our health span assessment, fill out, fill out our form.
- 10:38SPEAKER_01: Our team would love to talk to you.
- 10:39SPEAKER_01: See you on the next episode.
- 10:43SPEAKER_00: If you're feeling like your energy, your edge, or your clarity just isn't what it used to be, you're not alone.
- 10:48SPEAKER_01: But you're also not stuck.
- 10:50SPEAKER_01: Every week on Unbreakable Vitality, we explore real strategies to reverse aging, reclaim vitality, and rewrite what's possible.
- 10:59SPEAKER_01: If today's episode gave you even one insight, pass it on.
- 11:03SPEAKER_01: Then go take the free vascular age quiz at echelon longevity.comslash quiz to see how your body's aging.
- 11:11SPEAKER_01: Subscribe, leave a review, and follow us because your future isn't on autopilot.
- 11:16SPEAKER_01: You are building it and you're just getting started.